BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND BCL2, Bcl-2, 596, ENSG00000171791 AND Prognosis
112 results:

  • 1. Long non-coding RNA
    Wei Y; Zhu P
    Acta Pharm; 2024 Mar; 74(1):131-147. PubMed ID: 38554384
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.
    Sweed D; Elhamed SMA; Aiad HAS; Ehsan NA; Hemida AS; Dawoud MM
    World J Surg Oncol; 2024 Mar; 22(1):84. PubMed ID: 38532463
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/STAT3 pathway.
    Luo X; Ye Z; Xu C; Chen H; Dai S; Chen W; Bao G
    Mol Biol Rep; 2024 Jan; 51(1):176. PubMed ID: 38252208
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nicotine promotes epithelial to mesenchymal transition and gemcitabine resistance via hENT1/RRM1 signalling in pancreatic cancer and chemosensitizing effects of Embelin-a naturally occurring benzoquinone.
    Prashanth N ; Meghana P ; Sandeep Kumar Jain R ; Pooja S Rajaput ; Satyanarayan N D ; Raja Naika H ; Kumaraswamy H M
    Sci Total Environ; 2024 Mar; 914():169727. PubMed ID: 38163613
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Vitamin K: New insights related to senescence and cancer metastasis.
    Chen A; Li J; Shen N; Huang H; Hang Q
    Biochim Biophys Acta Rev Cancer; 2024 Mar; 1879(2):189057. PubMed ID: 38158025
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Actinomycin D synergizes with Doxorubicin in triple-negative breast cancer by inducing P53-dependent cell apoptosis.
    Yang H; Li S; Li W; Yang Y; Zhang Y; Zhang S; Hao Y; Cao W; Xu F; Wang H; Du G; Wang J
    Carcinogenesis; 2024 Apr; 45(4):262-273. PubMed ID: 37997385
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Increased mitochondria are responsible for the acquisition of gemcitabine resistance in pancreatic cancer cell lines.
    Masuo H; Kubota K; Shimizu A; Notake T; Miyazaki S; Yoshizawa T; Sakai H; Hayashi H; Soejima Y
    Cancer Sci; 2023 Nov; 114(11):4388-4400. PubMed ID: 37700464
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Reduced expression of phosphorylated ataxia-telangiectasia mutated gene is related to poor prognosis and gemcitabine chemoresistance in pancreatic cancer.
    Xun J; Ohtsuka H; Hirose K; Douchi D; Nakayama S; Ishida M; Miura T; Ariake K; Mizuma M; Nakagawa K; Morikawa T; Furukawa T; Unno M
    BMC Cancer; 2023 Sep; 23(1):835. PubMed ID: 37674118
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Aberrant expression of CKS2 induced by ELK1 contributes to malignant progression of pancreatic cancer.
    Chen Q; Fu Y; Liu X; Wang P; Dai S; Zhu F; Liu T; Xu W; Wu J
    Mol Carcinog; 2023 Dec; 62(12):1947-1959. PubMed ID: 37642304
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.
    Fu D; Yan J; Zhang Z; Liu Y; Ma X; Ding J; Yang S; Zhao R; Chang A; Gao C; Liu J; Zhao T; Wang X; Huang C; Gao S; Ma Y; Tang B; Feng Y; Wang H; Hao J
    Cancer Biol Med; 2023 Jun; 20(8):599-626. PubMed ID: 37381714
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Dihydrotanshinone I Inhibits pancreatic cancer Progression
    Huang W; Dai Y; Xu L; Mao Y; Huang Z; Ji X
    Curr Cancer Drug Targets; 2023; 23(9):731-741. PubMed ID: 37018533
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. miR-3,178 contributes to the therapeutic action of baicalein against hepatocellular carcinoma cells via modulating HDAC10.
    Qi J; Li J; Bie B; Shi M; Zhu M; Tian J; Zhu K; Sun J; Mu Y; Li Z; Guo Y
    Phytother Res; 2023 Jan; 37(1):295-309. PubMed ID: 36070933
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Atypical Mucin Expression Predicts Worse Overall Survival in Resectable pancreatic Ductal Adenocarcinoma.
    Qian Y; Gong Y; Liu Y; Chen Y; Wang R; Dai Z; Zou X; Tasiheng Y; Luo G; Lin X; Wang X; Cheng H; Yu X; Liu C
    J Immunol Res; 2022; 2022():7353572. PubMed ID: 35910854
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. bcl-2 and Noxa are potential prognostic indicators for patients with gastroenteropancreatic neuroendocrine neoplasms.
    Guo Y; Zhang L; Zhang N; Chen L; Luo Q; Liu M; Yang D; Chen J
    Endocrine; 2022 Oct; 78(1):159-168. PubMed ID: 35895181
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Involvement of elevated ASF1B in the poor prognosis and tumorigenesis in pancreatic cancer.
    Wang K; Hao Z; Fu X; Li W; Jiao A; Hua X
    Mol Cell Biochem; 2022 Jul; 477(7):1947-1957. PubMed ID: 35362843
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. In vitro assessment of a synergistic combination of gemcitabine and zebularine in pancreatic cancer cells.
    Patki M; Saraswat A; Bhutkar S; Dukhande V; Patel K
    Exp Cell Res; 2021 Aug; 405(2):112660. PubMed ID: 34048785
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Identification of an autophagy-related gene signature for survival prediction in patients with cervical cancer.
    Chen H; Deng Q; Wang W; Tao H; Gao Y
    J Ovarian Res; 2020 Nov; 13(1):131. PubMed ID: 33160404
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Baicalein flavone targets cisplatin resistant human pancreatic cancer cells via inducing S-phase cell cycle arrest, inhibition of cell migration and invasion, caspase activation and mitochondrial-dependent apoptosis.
    Zhang Y; Chen Z; Li X; He J; Liu Z; Yang L
    J BUON; 2020; 25(4):1947-1953. PubMed ID: 33099937
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Antiproliferative and apoptotic effect of ethanolic extract of Calocybe indica on PANC-1 and MIAPaCa2 cell lines of pancreatic cancer.
    Ghosh SK; Sanyal T
    Exp Oncol; 2020 Sep; 42(3):178-182. PubMed ID: 32996735
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. MiR-331-3p Links to Drug Resistance of pancreatic cancer Cells by Activating WNT/β-Catenin Signal via ST7L.
    Zhan T; Chen X; Tian X; Han Z; Liu M; Zou Y; Huang S; Chen A; Cheng X; Deng J; Tan J; Huang X
    Technol Cancer Res Treat; 2020; 19():1533033820945801. PubMed ID: 32924881
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.